Hemolytic anemia surgery: Difference between revisions

Jump to navigation Jump to search
Shyam Patel (talk | contribs)
No edit summary
Shyam Patel (talk | contribs)
Line 8: Line 8:


==Surgery==
==Surgery==
 
'''[[Splenectomy]] is a second-line therapy option and is typically done only if there is non-response to steroids. The response rate to splenectomy is usually 60-70%. Splenectomy is ideal for patients with extravascular hemolysis and Fc receptor mediated hemolysis, since the spleen in involved in the pathophysiology of these aspects of hemolytic anemia.<ref name="pmid26696797">{{cite journal| author=Salama A| title=Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 294-301 | pmid=26696797 | doi=10.1159/000438731 | pmc=4678315 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696797  }} </ref>
*Adverse effects: Given that this is a surgery, the risks and benefits must be carefully weighed, as surgical interventions typically have higher risks than medication interventions. Splenectomy carries an inherent surgical risk in addition to the risk for infections from encapsulated organisms, such as Neisseria meningitides, Streptococcus pneumoniae, and Hemophilus influenzae. Patients who plan to undergo splenectomy should be vaccinated prior to the surgery. In the current era, the surgical risk of splenectomy is likely lower than in the prior decades, as laparoscopic and minimally invasive approaches are used. Thrombosis is another risk of splenoectomy.<ref name="pmid26696797">{{cite journal| author=Salama A| title=Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 294-301 | pmid=26696797 | doi=10.1159/000438731 | pmc=4678315 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696797  }} </ref>
In some cases of extravascular hemolysis, [[splenectomy]] can be helpful. In this case, most of the red blood cells are being destroyed by the spleen, and surgical removal of the spleen can correct the underlying problem. Splenectomy can help the hemoglobin level to return towards baseline. The risks and benefits of splenoectomy should be weighed prior to proceeding with splenectomy. There is a high risk for asplenic sepsis with encapsulated organisms, such as Neisseria, Hemophilius, and Streptococcus.<ref name="pmid26543526">{{cite journal| author=Leone G, Pizzigallo E| title=Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases. | journal=Mediterr J Hematol Infect Dis | year= 2015 | volume= 7 | issue= 1 | pages= e2015057 | pmid=26543526 | doi=10.4084/MJHID.2015.057 | pmc=4621170 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26543526  }} </ref> Patients should be vaccinated against these organisms prior to spleen removal.
In some cases of extravascular hemolysis, [[splenectomy]] can be helpful. In this case, most of the red blood cells are being destroyed by the spleen, and surgical removal of the spleen can correct the underlying problem. Splenectomy can help the hemoglobin level to return towards baseline. The risks and benefits of splenoectomy should be weighed prior to proceeding with splenectomy. There is a high risk for asplenic sepsis with encapsulated organisms, such as Neisseria, Hemophilius, and Streptococcus.<ref name="pmid26543526">{{cite journal| author=Leone G, Pizzigallo E| title=Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases. | journal=Mediterr J Hematol Infect Dis | year= 2015 | volume= 7 | issue= 1 | pages= e2015057 | pmid=26543526 | doi=10.4084/MJHID.2015.057 | pmc=4621170 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26543526  }} </ref> Patients should be vaccinated against these organisms prior to spleen removal.



Revision as of 19:12, 23 October 2017

Hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT Scan

MRI Scan

Echocardiography or Ultrasound

Imaging Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic anemia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic anemia surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic anemia surgery

CDC on Hemolytic anemia surgery

Hemolytic anemia surgery in the news

Blogs on Hemolytic anemia surgery

Directions to Hospitals Treating Hemolytic anemia

Risk calculators and risk factors for Hemolytic anemia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Surgery

Splenectomy is a second-line therapy option and is typically done only if there is non-response to steroids. The response rate to splenectomy is usually 60-70%. Splenectomy is ideal for patients with extravascular hemolysis and Fc receptor mediated hemolysis, since the spleen in involved in the pathophysiology of these aspects of hemolytic anemia.[1]

  • Adverse effects: Given that this is a surgery, the risks and benefits must be carefully weighed, as surgical interventions typically have higher risks than medication interventions. Splenectomy carries an inherent surgical risk in addition to the risk for infections from encapsulated organisms, such as Neisseria meningitides, Streptococcus pneumoniae, and Hemophilus influenzae. Patients who plan to undergo splenectomy should be vaccinated prior to the surgery. In the current era, the surgical risk of splenectomy is likely lower than in the prior decades, as laparoscopic and minimally invasive approaches are used. Thrombosis is another risk of splenoectomy.[1]

In some cases of extravascular hemolysis, splenectomy can be helpful. In this case, most of the red blood cells are being destroyed by the spleen, and surgical removal of the spleen can correct the underlying problem. Splenectomy can help the hemoglobin level to return towards baseline. The risks and benefits of splenoectomy should be weighed prior to proceeding with splenectomy. There is a high risk for asplenic sepsis with encapsulated organisms, such as Neisseria, Hemophilius, and Streptococcus.[2] Patients should be vaccinated against these organisms prior to spleen removal.

References

  1. 1.0 1.1 Salama A (2015). "Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review". Transfus Med Hemother. 42 (5): 294–301. doi:10.1159/000438731. PMC 4678315. PMID 26696797.
  2. Leone G, Pizzigallo E (2015). "Bacterial Infections Following Splenectomy for Malignant and Nonmalignant Hematologic Diseases". Mediterr J Hematol Infect Dis. 7 (1): e2015057. doi:10.4084/MJHID.2015.057. PMC 4621170. PMID 26543526.

Template:WS Template:WH